and Broad, E
Cardinal von WiddernJHohmannTDehghaniF
Weight Management and Obesity Efficacy Clinical trials have demonstrated that cagrilintide effectively reduces body weight in individuals with obesity
As ALS progresses, over 80% of patients develop difficulty swallowing (dysphagia), and many also experience increased metabolism, which raises their calorie needs by about 1520% more normal (Dupuis and Chio, 2023)
Traditional growth hormone therapy carries risks including fluid retention, joint pain (paradoxically), carpal tunnel syndrome, and increased cancer risk
So far, BPC-157 has shown a low risk for toxicity and adverse reactions, even at higher doses, in multiple preclinical trials